Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
What sets GLP-1 receptor agonists apart is their broad impact
Sualska KD, Kasperkiewicz P: Exploring the involvement of serine proteases in neutrophil extracellular traps: a review of mechanisms and implications
Key takeaways Animal studies show BPC-157 improves gastric motility and protects against gastric damage in rats No human clinical trial has tested BPC-157 for gastroparesis specifically BPC-157 modulates the nitric oxide system and may interact with vagal nerve function, both relevant to gastroparesis Oral administration (250-500 mcg daily) is preferred over injection for GI-targeted effects BPC-157 is unusually stable in stomach acid, making oral delivery viable Patients should work with their gastroenterologist before adding BPC-157 to their gastroparesis management What is gastroparesis and why is it hard to treat
Marinaccio , U.S
PLoS ONE 11 , e0165592 (2016)
These insights set the stage for considering when and how to begin treatment responsibly
US$ 20.04
US$ 21.98
US$ 20.13
US$ 28.74
